1. Byvalson
- Author
-
Lowery, Mark
- Subjects
Allergan PLC -- Product development ,Antihypertensive agents -- Product development ,Valsartan -- Product development ,Nebivolol -- Product development ,Drug approval ,Business ,Pharmaceuticals and cosmetics industries ,Byvalson (Medication) -- Product development - Abstract
FDA has approved Allergan's Byvalson (nebivolol 5 mg and valsarian 80 mg) tablets. The drug is indicated to treat hypertension, and according to the product maker it is the first [...]
- Published
- 2016